Holen Sie sich die Stockscreener-App
2.4101
2.33%
0.0501
Schlusskurs vom Vortag:
$2.36
Offen:
$2.43
24-Stunden-Volumen:
540.28K
Relative Volume:
0.78
Marktkapitalisierung:
$192.95M
Einnahmen:
$63.63M
Nettoeinkommen (Verlust:
$10.62M
KGV:
48.20
EPS:
0.05
Netto-Cashflow:
$-8.64M
1W Leistung:
-7.12%
1M Leistung:
+33.43%
6M Leistung:
+0.21%
1J Leistung:
+123.61%
1-Tages-Spanne:
$2.36
$2.473
1-Wochen-Bereich:
$2.36
$2.655
52-Wochen-Spanne:
$1.01
$3.10
Protalix BioTherapeutics Inc. Stock (PLX) Company Profile
Firmenname
Protalix BioTherapeutics Inc.
Sektor
Branche
Telefon
972 4 988 9488
Adresse
2 Snunit Street, Science Park PO Box 455, Karmiel
Vergleichen Sie PLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLX
Protalix BioTherapeutics Inc.
|
2.42 | 188.17M | 63.63M | 10.62M | -8.64M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.71 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.21 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.58 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Protalix BioTherapeutics Inc. Stock (PLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-06-08 | Bestätigt | H.C. Wainwright | Buy |
| 2017-04-17 | Bestätigt | Rodman & Renshaw | Buy |
| 2016-04-04 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-04-23 | Hochstufung | Jefferies | Hold → Buy |
| 2014-11-12 | Bestätigt | R. F. Lafferty | Buy |
| 2014-01-24 | Eingeleitet | R. F. Lafferty | Buy |
| 2012-05-02 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2012-05-02 | Bestätigt | Oppenheimer | Outperform |
| 2012-04-30 | Herabstufung | Auriga | Buy → Hold |
| 2011-10-13 | Eingeleitet | Morgan Joseph | Hold |
| 2011-03-17 | Herabstufung | WBB Securities | Strong Buy → Buy |
| 2010-11-09 | Bestätigt | Oppenheimer | Outperform |
| 2010-10-14 | Bestätigt | UBS | Buy |
| 2009-12-02 | Bestätigt | Hapoalim | Outperform |
| 2009-09-22 | Eingeleitet | Canaccord Adams | Buy |
| 2009-09-02 | Eingeleitet | Hapoalim | Outperform |
| 2008-12-01 | Bestätigt | Oppenheimer | Outperform |
| 2008-03-11 | Eingeleitet | UBS | Buy |
| 2007-11-20 | Eingeleitet | CIBC Wrld Mkts | Sector Outperform |
Alle ansehen
Protalix BioTherapeutics Inc. Aktie (PLX) Neueste Nachrichten
How Protalix BioTherapeutics Inc. stock performs in weak economy2025 Key Highlights & Low Risk Investment Opportunities - newser.com
Published on: 2025-10-13 09:33:20 - newser.com
How to use Fibonacci retracement on Protalix BioTherapeutics Inc.July 2025 Market Mood & Low Risk High Reward Trade Ideas - newser.com
Is Protalix BioTherapeutics Inc. stock positioned for long term growthJuly 2025 Levels & Weekly High Return Opportunities - newser.com
Will breakout in Protalix BioTherapeutics Inc. lead to full recoveryWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
Relative strength of Protalix BioTherapeutics Inc. in sector analysisJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
Earnings visualization tools for Protalix BioTherapeutics Inc.Earnings Growth Report & Expert Verified Movement Alerts - newser.com
Can trapped investors hope for a rebound in Protalix BioTherapeutics Inc.2025 Price Targets & Safe Entry Momentum Stock Tips - newser.com
Can Protalix BioTherapeutics Inc. hit a new high this monthTrade Performance Summary & Smart Swing Trading Techniques - newser.com
Visual analytics tools that track Protalix BioTherapeutics Inc. performanceChart Signals & Capital Protection Trade Alerts - newser.com
Why Protalix BioTherapeutics Inc. stock could benefit from AI revolutionEarnings Recap Report & Low Risk Entry Point Tips - newser.com
Why Protalix BioTherapeutics Inc. (DE) stock appears on watchlistsJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - newser.com
Is Protalix BioTherapeutics Inc. (PBDA) stock considered safe haven2025 Key Lessons & Fast Gain Stock Tips - newser.com
Is this a good reentry point in Protalix BioTherapeutics Inc.July 2025 Retail & Growth Focused Stock Reports - newser.com
What analysts say about Protalix BioTherapeutics Inc stockSwing Trading Ideas & Next-Level Stock Intelligence, Now Free - earlytimes.in
Is it too late to sell Protalix BioTherapeutics Inc.Weekly Investment Report & Fast Moving Trade Plans - newser.com
What the charts say about Protalix BioTherapeutics Inc. todayJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Why Protalix BioTherapeutics Inc. (PBDA) stock gets analyst attention2025 Big Picture & Long-Term Growth Stock Strategies - newser.com
Is Protalix BioTherapeutics Inc. (DE) stock undervalued after correctionWeekly Earnings Recap & Long-Term Investment Growth Plans - newser.com
Statistical indicators supporting Protalix BioTherapeutics Inc.’s strengthEarnings Risk Summary & Free High Return Stock Watch Alerts - newser.com
Developing predictive dashboards with Protalix BioTherapeutics Inc. dataJuly 2025 Decliners & Long-Term Growth Plans - newser.com
Detecting price anomalies in Protalix BioTherapeutics Inc. with AIWeekly Stock Summary & Verified Entry Point Signals - newser.com
Published on: 2025-10-02 23:31:20 - newser.com
Published on: 2025-10-02 21:05:30 - newser.com
Published on: 2025-10-01 07:13:09 - newser.com
Finanzdaten der Protalix BioTherapeutics Inc.-Aktie (PLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):